On the other hand, another transgenic mouse with cardiac specific overexpression of HGF did not develop cardiac hypertrophy, indicating negative regulatory mechanisms on ligand-activated Met receptor signaling [102]. This evidence concerns the gene HGF and cardiac hypertrophy.